These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 24631139)

  • 21. Experimental diabetic nephropathy can be prevented by propolis: Effect on metabolic disturbances and renal oxidative parameters.
    Abo-Salem OM; El-Edel RH; Harisa GE; El-Halawany N; Ghonaim MM
    Pak J Pharm Sci; 2009 Apr; 22(2):205-10. PubMed ID: 19339234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. N-acetylcysteine protects against diabetic nephropathy through control of oxidative and nitrosative stress by recovery of nitric oxide in rats.
    Nogueira GB; Punaro GR; Oliveira CS; Maciel FR; Fernandes TO; Lima DY; Rodrigues AM; Mouro MG; Araujo SRR; Higa EMS
    Nitric Oxide; 2018 Aug; 78():22-31. PubMed ID: 29778909
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Renoprotective, anti-oxidative and anti-apoptotic effects of oral low-dose quercetin in the C57BL/6J model of diabetic nephropathy.
    Gomes IB; Porto ML; Santos MC; Campagnaro BP; Pereira TM; Meyrelles SS; Vasquez EC
    Lipids Health Dis; 2014 Dec; 13():184. PubMed ID: 25481305
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney.
    Anjaneyulu M; Chopra K
    Am J Nephrol; 2004; 24(5):488-96. PubMed ID: 15353911
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuation of inflammatory response by a novel chalcone protects kidney and heart from hyperglycemia-induced injuries in type 1 diabetic mice.
    Fang Q; Wang J; Wang L; Zhang Y; Yin H; Li Y; Tong C; Liang G; Zheng C
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):179-91. PubMed ID: 26206226
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nephroprotective effect of Combretum micranthum G. Don in nicotinamide-streptozotocin induced diabetic nephropathy in rats: In-vivo and in-silico experiments.
    Kpemissi M; Potârniche AV; Lawson-Evi P; Metowogo K; Melila M; Dramane P; Taulescu M; Chandramohan V; Suhas DS; Puneeth TA; S VK; Vlase L; Andrei S; Eklu-Gadegbeku K; Sevastre B; Veerapur VP
    J Ethnopharmacol; 2020 Oct; 261():113133. PubMed ID: 32673708
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibroblast growth factor 1 ameliorates diabetic nephropathy by an anti-inflammatory mechanism.
    Liang G; Song L; Chen Z; Qian Y; Xie J; Zhao L; Lin Q; Zhu G; Tan Y; Li X; Mohammadi M; Huang Z
    Kidney Int; 2018 Jan; 93(1):95-109. PubMed ID: 28750927
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Poly(ADP-ribose) polymerase (PARP) inhibition counteracts multiple manifestations of kidney disease in long-term streptozotocin-diabetic rat model.
    Shevalye H; Stavniichuk R; Xu W; Zhang J; Lupachyk S; Maksimchyk Y; Drel VR; Floyd EZ; Slusher B; Obrosova IG
    Biochem Pharmacol; 2010 Apr; 79(7):1007-14. PubMed ID: 19945439
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis.
    Mohamed R; Jayakumar C; Chen F; Fulton D; Stepp D; Gansevoort RT; Ramesh G
    J Am Soc Nephrol; 2016 Mar; 27(3):745-65. PubMed ID: 26334030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Flavonoid rich fraction of Punica granatum improves early diabetic nephropathy by ameliorating proteinuria and disturbed glucose homeostasis in experimental animals.
    Ankita P; Deepti B; Nilam M
    Pharm Biol; 2015 Jan; 53(1):61-71. PubMed ID: 25289530
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Amelioration of Diabetes-Induced Diabetic Nephropathy by Aloe vera: Implication of Oxidative Stress and Hyperlipidemia.
    Arora MK; Sarup Y; Tomar R; Singh M; Kumar P
    J Diet Suppl; 2019; 16(2):227-244. PubMed ID: 29621403
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mineralocorticoid receptor antagonist reduces renal injury in rodent models of types 1 and 2 diabetes mellitus.
    Guo C; Martinez-Vasquez D; Mendez GP; Toniolo MF; Yao TM; Oestreicher EM; Kikuchi T; Lapointe N; Pojoga L; Williams GH; Ricchiuti V; Adler GK
    Endocrinology; 2006 Nov; 147(11):5363-73. PubMed ID: 16901964
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attenuation of renal damage in type I diabetic rats by umbelliferone - a coumarin derivative.
    Garud MS; Kulkarni YA
    Pharmacol Rep; 2017 Dec; 69(6):1263-1269. PubMed ID: 29128808
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tyrosine kinase inhibitor, genistein, reduces renal inflammation and injury in streptozotocin-induced diabetic mice.
    Elmarakby AA; Ibrahim AS; Faulkner J; Mozaffari MS; Liou GI; Abdelsayed R
    Vascul Pharmacol; 2011; 55(5-6):149-56. PubMed ID: 21807121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Taurine ameliorates alloxan-induced diabetic renal injury, oxidative stress-related signaling pathways and apoptosis in rats.
    Das J; Sil PC
    Amino Acids; 2012 Oct; 43(4):1509-23. PubMed ID: 22302365
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Apigenin ameliorates streptozotocin-induced diabetic nephropathy in rats via MAPK-NF-κB-TNF-α and TGF-β1-MAPK-fibronectin pathways.
    Malik S; Suchal K; Khan SI; Bhatia J; Kishore K; Dinda AK; Arya DS
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F414-F422. PubMed ID: 28566504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of simvastatin on oxidative stress in streptozotocin-induced diabetic rats: a role for glomeruli protection.
    Zhu B; Shen H; Zhou J; Lin F; Hu Y
    Nephron Exp Nephrol; 2005; 101(1):e1-8. PubMed ID: 15886498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tropisetron ameliorates early diabetic nephropathy in streptozotocin-induced diabetic rats.
    Barzegar-Fallah A; Alimoradi H; Asadi F; Dehpour AR; Asgari M; Shafiei M
    Clin Exp Pharmacol Physiol; 2015 Apr; 42(4):361-8. PubMed ID: 25676798
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Angiotensin II type II receptor deficiency accelerates the development of nephropathy in type I diabetes via oxidative stress and ACE2.
    Chang SY; Chen YW; Chenier I; Tran Sle M; Zhang SL
    Exp Diabetes Res; 2011; 2011():521076. PubMed ID: 22110472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of Momordica grosvenori on oxidative stress pathways in renal mitochondria of normal and alloxan-induced diabetic mice. Involvement of heme oxygenase-1.
    Song F; Qi X; Chen W; Jia W; Yao P; Nussler AK; Sun X; Liu L
    Eur J Nutr; 2007 Mar; 46(2):61-9. PubMed ID: 17278042
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.